Surrogate endpoints with Huseyin Naci

Deep Breath In by The BMJ

Nov 11, 202247:13Science & Medicine

This week, we’re joined by Huseyin Naci to discuss the recent press release from Eisai and Biogen announcing the Phase III trial results for lecanemab for use in Alzheimer’s disease, and the FDA’s decision to accept the...

Related Episodes

Continue listening to more episodes from Deep Breath In.

The tyranny of 10 minutes - with Alice Harper, Carol Sinnott and Jess Watson

Mar 22, 2024 - 32:40

The BMJ's long running "10 minute consultation" series is being questioned - can you do everything we sug...

Is cancer screening worth it? with Michael Bretthauer

Nov 17, 2023 - 40:29

Is cancer screening worth it, and how can GPs have that conversation? This episode of Deep Breath In expl...

Greener GPs

Oct 27, 2023 - 47:14

As news about the climate breakdown hits, it's hard not to feel the stirring of climate anxiety. One way...

The known unknowns of menopause

Sep 27, 2023 - 44:07

There have been so many conflicting views in the media lately on the management of menopause, and HRT has...

Saying no, with Rachel Morris

Jul 28, 2023 - 57:09

There's never enough time in the day to be a GP, but it's still hard to say no to that one patient, or to...

Prostate cancer screening with Andrew Vickers and Sam Merriel

Jun 30, 2023 - 45:53

Common themes for discussion on this podcast include overdiagnosis, approaches to the testing, the ins an...

Long covid update with Trish Greenhalgh and Harsha Master

Jun 9, 2023 - 52:23

While the pandemic has officially declared over, the ongoing effects of a covid-19 infection are still be...

Supporting the sexual wellbeing of older adults - with Sharon Hinchliff and Rebecca Mawson

May 5, 2023 - 66:49

Talking about sexual health may be common-place with younger patients, but the sexual wellbeing of older...